Pulse lineResearch With Heart Logo

ARIC Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
McEvoy JW, Lazo M, Chen Y, et al. "Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study." Int J Cardiol. 2015;187:651-7.
Fang M, Tcheugui JBEchouffo, Pankow JS, B Windham G, Selvin E. "Patient-reported preventive care practices in older adults with diabetes." Diabet Med. 2021;38(3):e14508.
Zhao J, Zhu Y, Boerwinkle E. "Pathway analysis with next-generation sequencing data." Eur J Hum Genet. 2015;23(4):507-15.
Tabor HK, Auer PL, Jamal SM, et al. "Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results." Am J Hum Genet. 2014;95(2):183-93.
Melnick SL, Shahar E, Folsom AR, et al. "Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators." Am J Med. 1993;95(5):499-504.
Naimark DMJ, Grams ME, Matsushita K, et al. "Past Decline Versus Current eGFR and Subsequent Mortality Risk." J Am Soc Nephrol. 2016;27(8):2456-66.
Kovesdy CP, Coresh JJ, Ballew SH, et al. "Past Decline Versus Current eGFR and Subsequent ESRD Risk." J Am Soc Nephrol. 2016;27(8):2447-55.
Dixit S, Alonso A, Vittinghoff E, Soliman EZ, Chen LYee. "Past alcohol consumption and incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study." PLoS One. 2017;12(10):e0185228.
Blum MF, Surapaneni A, Stewart JD, et al. "Particulate Matter and Albuminuria, Glomerular Filtration Rate, and Incident CKD." Clin J Am Soc Nephrol. 2020;15(3):311-319.
Nicholson WK, Asao K, Brancati F, Coresh J, Pankow JS, Powe NR. "Parity and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study." Diabetes Care. 2006;29(11):2349-54.
Perry JRb, Day F, Elks CE, et al. "Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche." Nature. 2014;514(7520):92-97.
Morrison AC, Fornage M, Liao D, Boerwinkle E. "Parental history of stroke predicts subclinical but not clinical stroke: the Atherosclerosis Risk in Communities Study." Stroke. 2000;31(9):2098-102.
Reis JP, Selvin E, Pankow JS, Michos ED, Rebholz CM. "Parathyroid hormone is associated with incident diabetes in white, but not black adults: The Atherosclerosis Risk in Communities (ARIC) Study." Diabetes Metab. 2016;42(3):162-9.
Folsom AR, Alonso A, Misialek JR, et al. "Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2014;168(3):296-302.
Yao L, Folsom AR, Pankow JS, et al. "Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study." J Hypertens. 2016;34(2):196-203.
Korada SKrishna C, Zhao D, Gottesman RF, et al. "Parathyroid Hormone and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging Study." J Stroke Cerebrovasc Dis. 2016;25(4):883-93.
Paynter NP, A Sharrett R, Louis TA, Rosamond W, Folsom AR, Coresh J. "Paired comparison of observed and expected coronary heart disease rates over 12 years from the Atherosclerosis Risk in Communities Study." Ann Epidemiol. 2010;20(9):683-90.
Magnani JW, Lopez FL, Soliman EZ, Maclehose RF, Crow RS, Alonso A. "P wave indices, obesity, and the metabolic syndrome: the atherosclerosis risk in communities study." Obesity (Silver Spring). 2012;20(3):666-72.
O
Singer RE, Moss K, Kim SJ, Beck JD. "Oxidative Stress and IgG Antibody Modify Periodontitis-CRP Association." J Dent Res. 2015;94(12):1698-705.
Houston DK, Cai J, Stevens J. "Overweight and obesity in young and middle age and early retirement: the ARIC study." Obesity (Silver Spring). 2009;17(1):143-9.
Olden M, Teumer A, Bochud M, et al. "Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium." Am J Kidney Dis. 2013;61(6):889-98.
Caughey MC, Avery CL, Ni H, et al. "Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance)." Am J Cardiol. 2014;114(12):1850-4.
Arora S, Cavender MA, Chang PP, et al. "Outcomes of decreasing versus increasing cardiac troponin in patients admitted with non-ST-segment elevation myocardial infarction: the Atherosclerosis Risk in Communities Surveillance Study." Eur Heart J Acute Cardiovasc Care. 2019:2048872619842983.
Zhou Q, Cai J. "Outcome-dependent sampling with interval-censored failure time data." Biometrics. 2018;74(1):58-67.
Rose KM, Eigenbrodt ML, Biga RL, et al. "Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study." Circulation. 2006;114(7):630-6.
Juraschek SP, Daya N, Appel LJ, et al. "Orthostatic Hypotension in Middle-Age and Risk of Falls." Am J Hypertens. 2017;30(2):188-195.
Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D. "Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996." Stroke. 2000;31(10):2307-13.
Jones CD, Loehr L, Franceschini N, et al. "Orthostatic hypotension as a risk factor for incident heart failure: the atherosclerosis risk in communities study." Hypertension. 2012;59(5):913-8.
Rose KM, Tyroler HA, Nardo CJ, et al. "Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities study." Am J Hypertens. 2000;13(6 Pt 1):571-8.
Bell EJ, Agarwal SK, Cushman M, Heckbert SR, Lutsey PL. "Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies." Am J Hypertens. 2016;29(5):634-40.
Juraschek SP, Daya N, Appel LJ, et al. "Orthostatic Hypotension and Risk of Clinical and Subclinical Cardiovascular Disease in Middle-Aged Adults." J Am Heart Assoc. 2018;7(10).
Fedorowski A, Franceschini N, Brody J, et al. "Orthostatic hypotension and novel blood pressure-associated gene variants: Genetics of Postural Hemodynamics (GPH) Consortium." Eur Heart J. 2012;33(18):2331-41.
Franceschini N, Rose KM, Astor BC, Couper D, Vupputuri S. "Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study." Hypertension. 2010;56(6):1054-9.
Rose KM, Couper D, Eigenbrodt ML, Mosley TH, A Sharrett R, Gottesman RF. "Orthostatic hypotension and cognitive function: the Atherosclerosis Risk in Communities Study." Neuroepidemiology. 2010;34(1):1-7.
Agarwal SK, Alonso A, Whelton SP, et al. "Orthostatic change in blood pressure and incidence of atrial fibrillation: results from a bi-ethnic population based study." PLoS One. 2013;8(11):e79030.
Chekmeneva E, Correia GDos Santos, Chan Q, et al. "Optimization and Application of Direct Infusion Nanoelectrospray HRMS Method for Large-Scale Urinary Metabolic Phenotyping in Molecular Epidemiology." J Proteome Res. 2017;16(4):1646-1658.
Nunez E, Arnett DK, Benjamin EJ, et al. "Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study." Hypertension. 2005;45(1):58-63.
Kucharska-Newton AMaria, Palta P, Burgard S, et al. "Operationalizing Frailty in the Atherosclerosis Risk in Communities Study Cohort." J Gerontol A Biol Sci Med Sci. 2017;72(3):382-388.
Kim H, Rebholz CM, Garcia-Larsen V, Steffen LM, Coresh JJ. "Operational Differences in Plant-Based Diet Indices Affect the Ability to Detect Associations with Incident Hypertension in Middle-Aged US Adults." J Nutr. 2020;150(4):842-850.
H Y Wu J, Marklund M, Imamura F, et al. "Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies." Lancet Diabetes Endocrinol. 2017;5(12):965-974.
Xu J, Gaddis NC, Bartz TM, et al. "Omega-3 Fatty Acids and Genome-Wide Interaction Analyses Reveal DPP10-Pulmonary Function Association." Am J Respir Crit Care Med. 2019;199(5):631-642.
Palta P, Chen H, Deal JA, et al. "Olfactory function and neurocognitive outcomes in old age: The Atherosclerosis Risk in Communities Neurocognitive Study." Alzheimers Dement. 2018;14(8):1015-1021.
Boland LL, Folsom AR, Sorlie PD, et al. "Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study)." Am J Cardiol. 2002;90(9):927-31.
Evenson KR, Rosamond WD, Cai J, Pereira MA, Ainsworth BE. "Occupational physical activity in the atherosclerosis risk in communities study." Ann Epidemiol. 2003;13(5):351-7.
Bidulescu A, Rose KM, Wolf SH, Rosamond WD. "Occupation recorded on certificates of death compared with self-report: the Atherosclerosis Risk in Communities (ARIC) Study." BMC Public Health. 2007;7:229.
Mirabelli MC, London SJ, Charles LE, Pompeii LA, Wagenknecht LE. "Occupation and three-year incidence of respiratory symptoms and lung function decline: the ARIC Study." Respir Res. 2012;13:24.
Mirabelli MC, London SJ, Charles LE, Pompeii LA, Wagenknecht LE. "Occupation and the prevalence of respiratory health symptoms and conditions: the Atherosclerosis Risk in Communities Study." J Occup Environ Med. 2012;54(2):157-65.
Full KM, Jackson CL, Rebholz CM, Matsushita K. "Obstructive Sleep Apnea, Other Sleep Characteristics, and Risk of CKD in the Atherosclerosis Risk in Communities Sleep Heart Health Study." J Am Soc Nephrol. 2020;31(8):1859-1869.
Patwardhan AA, Larson MG, Levy D, et al. "Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample." Sleep. 2006;29(10):1301-6.
Nagayoshi M, Punjabi NM, Selvin E, et al. "Obstructive sleep apnea and incident type 2 diabetes." Sleep Med. 2016;25:156-161.
Lutsey PL, Bengtson LGS, Punjabi NM, et al. "Obstructive Sleep Apnea and 15-Year Cognitive Decline: The Atherosclerosis Risk in Communities (ARIC) Study." Sleep. 2016;39(2):309-16.
Offenbacher S, Beck JD, Barros SP, Suruki RY, Loewy ZG. "Obstructive airway disease and edentulism in the atherosclerosis risk in communities (ARIC) study." BMJ Open. 2012;2(6).
Ndumele CE, Coresh JJ, Lazo M, et al. "Obesity, subclinical myocardial injury, and incident heart failure." JACC Heart Fail. 2014;2(6):600-7.
Adabag S, Huxley RR, Norby FL, et al. "Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study." Heart. 2015;101(3):215-21.
Dearborn JL, Schneider ALC, Sharrett ARichey, et al. "Obesity, Insulin Resistance, and Incident Small Vessel Disease on Magnetic Resonance Imaging: Atherosclerosis Risk in Communities Study." Stroke. 2015;46(11):3131-6.
Wofford MR, Andrew ME, Brown A, et al. "Obesity Hypertension in the Atherosclerosis Risk in Communities Cohort: Implications of Obesity Guidelines." J Clin Hypertens (Greenwich). 1999;1(1):27-32.
Raffield LM, Howard AGreen, Graff M, et al. "Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study." J Am Heart Assoc. 2021;10(24):e019946.
Bryant MJ, Stevens J, Truesdale KP, Mosley T, Chambless L. "Obesity and vital exhaustion: analysis of the Atherosclerosis Risk in the Communities study." Obesity (Silver Spring). 2008;16(7):1545-51.
Ndumele CE, Matsushita K, Lazo M, et al. "Obesity and Subtypes of Incident Cardiovascular Disease." J Am Heart Assoc. 2016;5(8).
N
Bower JK, Lazo M, Matsushita K, Rubin J, Hoogeveen RC, Ballantyne CM. "N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study." Am J Hypertens. 2015;28(10):1262-6.
Ndumele CE, Matsushita K, Sang Y, et al. "N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study." Circulation. 2016;133(7):631-8.
Whitman IR, Vittinghoff E, Defilippi CR, et al. "NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure." J Am Heart Assoc. 2019;8(7):e010868.
Heard-Costa NL, Zillikens CM, Monda KL, et al. "NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium." PLoS Genet. 2009;5(6):e1000539.
Raynor LA, Pankow JS, Duncan BB, et al. "Novel risk factors and the prediction of type 2 diabetes in the Atherosclerosis Risk in Communities (ARIC) study." Diabetes Care. 2013;36(1):70-6.
Matsushita K, Sang Y, Chen J, et al. "Novel "Predictor Patch" Method for Adding Predictors Using Estimates From Outside Datasets - A Proof-of-Concept Study Adding Kidney Measures to Cardiovascular Mortality Prediction." Circ J. 2019;83(9):1876-1882.
Blumenthal JB, Andersen RE, Mitchell BD, et al. "Novel neuropeptide Y1 and Y5 receptor gene variants: associations with serum triglyceride and high-density lipoprotein cholesterol levels." Clin Genet. 2002;62(3):196-202.
Astor BC, Shafi T, Hoogeveen RC, et al. "Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population." Am J Kidney Dis. 2012;59(5):653-62.
Zhang S, Divaris K, Moss K, et al. "The Novel Locus is Associated with Severe Gingival Inflammation." JDR Clin Trans Res. 2016;1(2):163-170.
Dastani Z, Hivert M-F, Timpson N, et al. "Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals." PLoS Genet. 2012;8(3):e1002607.
Butler AM, Yin X, Evans DS, et al. "Novel loci associated with PR interval in a genome-wide association study of 10 African American cohorts." Circ Cardiovasc Genet. 2012;5(6):639-46.
Suri FMK, Yamagishi K, Aleksic N, Hannan PJ, Folsom AR. "Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study." Cerebrovasc Dis. 2010;29(5):497-502.
Lubitz SA, Lunetta KL, Lin H, et al. "Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese." J Am Coll Cardiol. 2014;63(12):1200-1210.
Adams HHH, Hibar DP, Chouraki V, et al. "Novel genetic loci underlying human intracranial volume identified through genome-wide association." Nat Neurosci. 2016;19(12):1569-1582.
Jensen RA, Sim X, Smith A V, et al. "Novel Genetic Loci Associated With Retinal Microvascular Diameter." Circ Cardiovasc Genet. 2016;9(1):45-54.
Hibar DP, Adams HHH, Jahanshad N, et al. "Novel genetic loci associated with hippocampal volume." Nat Commun. 2017;8:13624.
Feitosa MF, Kraja AT, Chasman DI, et al. "Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries." PLoS One. 2018;13(6):e0198166.
Holmes MV, Exeter HJ, Folkersen L, et al. "Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levels." Circ Cardiovasc Genet. 2014;7(2):144-50.
Smith NL, Chen M-H, Dehghan A, et al. "Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium." Circulation. 2010;121(12):1382-92.
Geurts YM, Dugué P-A, Joo JE, et al. "Novel associations between blood DNA methylation and body mass index in middle-aged and older adults." Int J Obes (Lond). 2018;42(4):887-896.
Huxley RR, Lopez FL, Maclehose RF, et al. "Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study." PLoS One. 2013;8(3):e59052.

Pages